Skip to main content

Table 2 Presenting clinical and laboratory features

From: Childhood Takayasu arteritis: disease course and response to therapy

Presenting features

Patients (N = 27)

Symptoms:

  

 Constitutional:

Malaise

13 (48)

Weight loss

8 (30)

Fever (> 38.0 C)

5 (19)

Lymphadenopathy

3 (11)

 Cardiovascular:

Claudication of the extremities

6 (22)

 Neurological:

Headache

9 (33)

Dizziness

5 (19)

Stroke/TIA

3 (11)

Syncope

3 (11)

 Gastrointestinal:

Chronic nausea/vomiting

5 (19)

Nonspecific abdominal pain

4 (15)

 Pulmonary:

Shortness of breath

4 (15)

Chest pain

3 (11)

 Musculoskeletal:

Back pain

5 (19)

 Ocular:

Blurred vision/uveitis/retinal hemorrhage

4 (15)

Findings on clinical exam:

 

Blood pressure discrepancy

18 (67)

Decreased or absent pulse

16 (59)

Arterial hypertension

15 (56)

Bruits over large arteries

15 (56)

Laboratory characteristics:

 

ESR, mm/h

35 (17–74)

CRP, mg/dL

31.9 (5.3–67.6)

Hemoglobin, g/L

115 (96.5–125.5)

White blood cells, × 10^9/L

8.8 (6.9–12.4)

Platelets, × 10^9/L

366 (256–543)

vWF antigen, IU/mL

1.6 (1.1–2.0)

Impaired renal function

2 (7)

ANA

8/22 (36)

ANCA

2/18 (11)

  1. Clinical features present in > 10% of the patients with childhood TAK are listed. Impaired renal function was defined as a creatinine increase of > 30% of the upper normal limit at diagnosis. Values are presented as numbers (%) or medians (IQR)
  2. TIA transient ischemic attack, ESR erythrocyte sedimentation rate, CRP C-reactive protein, vWF antigen von Willebrand factor antigen. ANA antinuclear antibody, ANCA antineutrophil cytoplasmic antibody